Author

Emily Durie

Institute of Cancer ResearchORCID 0000-0002-3474-0125Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Alan A. MelcheriD· 1 shared Amy BurleyiD· 1 shared Anna Clare WilkinsiD· 1 shared Anna MikolajczakiD· 1 shared Ben O’LearyiD· 1 shared Daniel ShewringiD· 1 shared Emma Connick· 1 shared Emma L. NyeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rapid expansion of podoplanin-positive fibroblasts following radiation limits the anti-tumour CD8+ T-cell response to radiotherapy.

Anna Clare Wilkins, Spyridon Makris, Mary J. Green, Steven Hooper, Anna Mikolajczak, Giovanni Giangreco, Srinivas Allanki, Emma L. Nye, Emma Connick, Richard Mitter, Sam Cooper, Emily Durie, Malin Pedersen, Amy Burley, Katie O’Fee, , Erik A. Sahai

This study shows that radiation-induced podoplanin-positive fibroblasts limit CD8+ T-cell access to tumour cells, reducing radiotherapy effectiveness, and that disrupting PDPN signaling enhances tumour control.

bioRxiv · Oct 7, 2025 · PreprintCancer Biology